Therapeutic drug monitoring of amikacin in septic patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic drug monitoring of amikacin in septic patients

Published:2013 Issue:4 Volume:17 Page:R165
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Critical Care

Author:

Duszynska Wieslawa,Taccone Fabio,Hurkacz Magdalena,Kowalska-Krochmal Beata,Wiela-Hojeńska Anna,Kübler Andrzej

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Reference27 articles.

1. Drug treatment for multidrug-resistant Acinetobacter baumannii infections

2. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection

3. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008

4. Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

5. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics reveals the mechanism of action of meropenem and amikacin combined in the treatment of Pseudomonas aeruginosa;Frontiers in Cellular and Infection Microbiology;2023-12-05

2. International survey of antibiotic dosing and monitoring in adult intensive care units;Critical Care;2023-06-19

3. Antimicrobial Stewardship on Patients with Neutropenia: A Narrative Review Commissioned by Microorganisms;Microorganisms;2023-04-26

4. Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections;International Journal of Pharmaceutics;2023-03

5. Development of a Predictive Dosing Nomogram to Achieve PK/PD Targets of Amikacin Initial Dose in Critically Ill Patients: A Non-Parametric Approach;Antibiotics;2023-01-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3